| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75a4811e7eae15e0f1e32cc6a222ce30 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-01 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P1-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-04 |
| filingDate |
1982-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c203734ad1437ab3e3bb4e9d54041dc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_643944addb2a0d93a9d40268ed8a14eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c187bea419fbbee35f2c4294741226a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18473fd208fda0d70065541ef443d4b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59247fccabdb18bbba47d44460b07a09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14589f0f3090303a942a78e7f2ae1a3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14f5aa8530c593f2acbf7813acc1c9ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93e875643be722fd6e6ea8211617fb8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0808fd3e6961560e5a90478d6c17872d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fb5b38248fa9f549bf5c5d32c1068cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e42cc695956042695cf76f9ce1279fd |
| publicationDate |
1983-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DD-202891-A5 |
| titleOfInvention |
NEW CARCINOSTATIC AND IMMUNOSTIMULATING SUBSTANCES, METHOD FOR THE PRODUCTION THEREOF AND CARCINOSTATIC AGENTS WITH A CONTENT OF THE SAME |
| abstract |
There are new TF-2 substances m. carcinostatic and. immunostimulating action. You will receive a. d. Culture mass or the supernatant fluid, which is obtained by culturing a bacterial strain of the genus Fusobacterium. The substances are useful for the treatment of cancers in mammals and humans. The description refers to the substances themselves as well as to methods of making the same and to a carcinostatic agent containing the same. |
| priorityDate |
1981-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |